Stay updated on Tolebrutinib in NRSPMS Clinical Trial
Sign up to get notified when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.

Latest updates to the Tolebrutinib in NRSPMS Clinical Trial page
- Check6 days agoChange DetectedLocation entries for Gurgaon, India were adjusted for consistent spelling (diacritic removed), leaving the rest of the study details unchanged.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision updated to v3.5.2. The previous v3.5.0 entry was removed.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded Gūrgaon, India, 122001 and 122002 as site entries with macronized spelling and removed the corresponding plain Gurgaon entries (122001 and 122002); Revision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check42 days agoChange DetectedStandardized the India locations by replacing the diacritic spelling Gūrgaon with Gurgaon for site IDs 122001 and 122002.SummaryDifference0.0%

- Check50 days agoChange DetectedTwo India study site entries were updated from Gurgaon 122001 and 122002 to Gūrgaon 122001 and 122002, and the revision was bumped to v3.4.3.SummaryDifference0.0%

- Check57 days agoChange DetectedTwo new Gurgaon, India locations (122001 and 122002) were added and the Gūrgaon spellings for these entries were removed.SummaryDifference0.0%

Stay in the know with updates to Tolebrutinib in NRSPMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.